Pressure BioSciences Issues Call Notice on Warrants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has issued a call notice to holders of its outstanding warrants, the firm said in a filing with the US Securities and Exchange Commission today.

The firm said that each outstanding warrant will continue to be exercisable for preferred stock at an exercise price of $12.50 per share until the close of business on April 27, 2010. On April 28, 2010, any unexercised warrants will be terminated and no longer be exercisable, according to the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.